(Q42323954)

26 October 2017

COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells (English)

1 reference

26 October 2017

4

David T Curiel

1 reference

26 October 2017

Victor Prima

1

1 reference

26 October 2017

Lyudmila N Kaliberova

series ordinal

2

1 reference

26 October 2017

Sergey Kaliberov

series ordinal

3

1 reference

26 October 2017

Sergei Kusmartsev

series ordinal

5

1 reference

26 October 2017

language of work or name

English

0 references

publication date

17 January 2017

1 reference

Proceedings of the National Academy of Sciences of the United States of America

26 October 2017

1 reference

26 October 2017

114

1 reference

26 October 2017

5

1 reference

26 October 2017

1117-1122

1 reference

describes a project that uses

26 October 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5293015/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Pembrolizumab for the treatment of non-small-cell lung cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Pembrolizumab versus Ipilimumab in Advanced Melanoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Coordinated regulation of myeloid cells by tumours

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Regulation of immune responses by prostaglandin E2

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

29 May 2018

Eicosanoids and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Enhancing the efficacy of cancer vaccines in urologic oncology: new directions

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Membrane prostaglandin E synthase-1: a novel therapeutic target

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5293015

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28096371

12 December 2020

inferred from PubMed ID database lookup

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28096371

12 December 2020

inferred from PubMed ID database lookup

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28096371

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1073/PNAS.1612920114

1 reference

26 October 2017

1 reference

26 October 2017

1 reference